Official recall notice

FDA DrugClass IINotable

FDA Recall: Phenylephrine Hydrochloride Injectable Solution, 40mg, 250*mL Bag, wells pharma of Houston, NDC 7370

Recall date
2026-05-06
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

cGMP deviations.

Recommended action

What to do

13,070 IV Bags

Product description

cGMP deviations.

Verify with the official notice →
Share:

Related Recalls

2026-05-06 · FDA_DRUG
FDA Recall: fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mcg/ 250 mL) (10 mcg p
Wells Pharma of Houston LLC
2026-05-06 · FDA_DRUG
FDA Recall: fentaNYL Citrate Injectable Solution, NARCOTIC, Cii, 1000 mcg/100 mL (10 mcg per mL), 100 mL bag, We
Wells Pharma of Houston LLC
2026-05-06 · FDA_DRUG
FDA Recall: fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pha
Wells Pharma of Houston LLC
2026-05-06 · FDA_DRUG
FDA Recall: fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells phar
Wells Pharma of Houston LLC